Patent US4447526A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4447526A Expired / Lapsed US ⏱️ 0.0 years remaining

Homogeneous specific binding assay with carrier matrix incorporating specific binding partner

Assignee: Bayer Corp
•
Filing: 1981-04-20
•
Granted: 1984-05-08
•
Expires: 2001-04-20
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method for determining the presence of a ligand in, or the ligand binding capacity of a liquid test sample which includes the steps of (a) adding to the sample a conjugate of the ligand and a label, (b) contacting the sample with a test device containing reagents which in conjunction with the conjugate and ligand, are capable of producing a detectable response, and (c) measuring the response.

Inventors

  • 👤 Patricia A. Rupchock
  • 👤 Richard J. Tyhach

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-31 12:49
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/536; G01N33/542; Y; Y10; Y10S; Y10S435/00; Y10S435/805; Y10S435/971; Y10S436/00; Y10S436/807; Y10S436/81

Claims Analysis

Total Claims: 17
Claim 1
Independent Claim 146 words
A method for determining the presence of a ligand in, or the ligand binding capacity of a liquid test sample, the method comprising the steps of forming a solution or suspension of a labeled conjugate and the liquid sample, the conjugate comprising the ligand or a specific binding analog of the ligand and a label, whereby a characteristic of the label is different when the conjugate is bound by a specific binding partner for said ligand or analog, compared to when said conjugate is not so bound, said difference in said characteristic being detectable, contacting said sample with a carrier matrix incorporated with reagents which, when in the presence of said conjugate, produce a homogeneous specific binding assay system wherein said difference in said label characteristic is detectable, said reagents comprising said specific binding partner, thereby producing said difference in said characteristic, and measuring said difference.
Claim 2
Independent Claim 146 words
A method for determining the presence of a ligand in, or the ligand binding capacity of a liquid test sample, the method comprising the steps of forming a solution or suspension of a labeled conjugate and the liquid sample, the conjugate comprising the ligand or a specific binding analog of the ligand and a label, whereby a characteristic of the label is different when the conjugate is bound by a specific binding partner for said ligand or analog, compared to when said conjugate is not so bound, said difference in said characteristic being detectable, contacting said sample with a carrier matrix incorporated with reagents which, when in the presence of said conjugate, produce a homogeneous specific binding assay system wherein said difference in said label characteristic is detectable, said reagents comprising said specific binding partner, thereby producing said difference in said characteristic, and measuring said difference.
Claim 3
Dependent Claim 13 words
The method of claim 1 wherein said difference is measured by human observation.
Claim 4
Dependent Claim 13 words
The method of claim 1 wherein said difference is measured by instrumental means.
Claim 5
Dependent Claim 17 words
The method of claim 1 wherein said carrier matrix comprises a substance absorbent to said liquid sample.
Claim 6
Dependent Claim 11 words
The method of claim 1 wherein said carrier matrix is paper.
Claim 7
Dependent Claim 15 words
The method of claim 1 wherein said carrier matrix comprises a polymeric film or gel.
Claim 8
Dependent Claim 13 words
The method of claim 1 wherein said label participates in an enzymatic reaction.
Claim 9
Dependent Claim 14 words
The method of claim 7 wherein said label is a substrate for an enzyme.
Claim 10
Dependent Claim 21 words
The method of claim 8 wherein said enzyme is capable of acting on said substrate label to produce a detectable product.
Claim 11
Dependent Claim 11 words
The method of claim 9 wherein said detectable product is fluorescent.
Claim 12
Dependent Claim 28 words
The method of claim 7 wherein said label is a prosthetic group of an enzyme, said groups being capable of combining with an apoenzyme to form said enzyme.
Claim 13
Dependent Claim 18 words
The method of claim 11 wherein said label comprises flavin adenine dinucleotide and said apoenzyme is apoglucose oxidase.
Claim 14
Dependent Claim 16 words
The method of claim 1 wherein difference is the appearance of or a change in color.
Claim 15
Dependent Claim 17 words
The method of claim 1 wherein said difference is the appearance of or a change in chemiluminescence.
Claim 16
Dependent Claim 17 words
The method of claim 1 wherein said difference is the appearance of or a change in fluorescence.
Claim 17
Dependent Claim 25 words
The method of claim 1 in which said difference is the appearance of or change in fluorescence, chemiluminescence, phosphorescence, light absorption, light reflectance or color.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-05-08 1987-11-07 1988-05-08 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-05-08 1991-11-07 1992-05-08 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-05-08 1995-11-07 1996-05-08 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag